CA
NZ
UK
AU
IND
US
Vistagen Therapeutics, Inc. (NASDAQ:VTGN)Penny Stocksold off after publishing an updated corporate presentation setting out, side by side, the results of four late-stage trials of its lead drug, fasedienol, along with a plan for a fifth. Of four Phase 3 studies in social anxiety disorder, …
● Regenlab USA filed an S-1 to list onNasdaqunder RGNA, without yet setting a share count or price range.
Teladoc Health (NYSE:TDOC), the virtual healthcare company, slipped after disclosing that Chief Legal Officer and Secretary Adam C. Vandervoort submitted his resignation on September 24, 2026, effective November 1, 2026. Jonathan Dorfman, currently Senior Vice President of Securities and Corporate Law, will step up …
Silexion Therapeutics (NASDAQ:SLXN) Penny Stock, a clinical-stage biotech with aMarket Valueof roughly $1.5 million, rose during Friday's regular session before sliding in after-hours trading once the company disclosed that shareholders had rejected two key proposals at a twice-adjourned extraordinary general meeting.
● Jaguar Health issued 729,989 shares to StreetervilleCapitalon September 23, 2026 to pay down two secured promissory notes.
● The board approved issuing 1,980,000 Class A and 500,000 Class C shares to six directors and officers.
● Interpace filed an S-1 for a $20 million common stock offering underwritten solely by Lake Street Capital Markets.
● IM Cannabis sold 655,000 common shares at $2.00 each on September 24, 2026, raising about $1.31 million in gross proceeds.
Nektar Therapeutics (NASDAQ:NKTR) came into the session with a courtroom victory to celebrate: a federal jury in the Northern District of California found that Eli Lilly had breached the implied covenant of good faith and fair dealing in its license agreement for rezpegaldesleukin, the …
● GT Biopharma regainedNasdaqbid price compliance after closing above $1.00 for ten consecutiveBusinessdays as of September 22, 2026.
Please wait processing your request...